Quick Answer
RIGEL PHARMACEUTICALS INC reported Earnings Per Share Diluted of $19.48 per share for the year ending 2025.
- RIGEL PHARMACEUTICALS INC showed an increase of +1,867.7% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from RIGEL PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on March 3, 2026.
- XBRL data for this metric is available from 2009 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 11 years of available data (2009 to 2025), RIGEL PHARMACEUTICALS INC's Earnings Per Share Diluted has grown by 813.6%.
- Historical annual values: Fiscal year 2025: $19.48 per share | Fiscal year 2024: $0.99 per share | Fiscal year 2023: $1.44 (loss) per share | Fiscal year 2022: $3.44 (loss) per share | Fiscal year 2021: $0.11 (loss) per share | Fiscal year 2020: $0.18 (loss) per share | Fiscal year 2019: $0.40 (loss) per share | Fiscal year 2012: $1.32 (loss) per share | Fiscal year 2011: $1.36 (loss) per share | Fiscal year 2010: $0.72 per share | Fiscal year 2009: $2.73 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: